Full text

Turn on search term navigation

© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Degeneration of retinal pigment epithelium (RPE) is one of the most critical phenotypic changes of age-related macular degeneration (AMD), the leading cause of vision loss in the elderly. While cultured polarized RPE cells with original properties are valuable in in vitro models to study RPE biology and the consequences of genetic and/or pharmacological manipulations, the procedure to establish mouse primary PRE cell culture or pluripotent stem cell-derived RPE cells is time-consuming and yields a limited number of cells. Thus, establishing a mouse in situ RPE culture system is highly desirable. Here we describe a novel and efficient method for RPE explant culture that allows for obtaining biologically relevant RPE cells in situ. These RPE explants (herein referred to as RPE flatmounts) are viable in culture for at least 7 days, can be efficiently transduced with adenoviral constructs, and/or treated with a variety of drugs/chemicals followed by downstream analysis of the signaling pathways/biological processes of interest, such as assessment of the autophagy flux, inflammatory response, and receptor tyrosine kinases stimulation. This method of RPE explant culture is highly beneficial for pharmacological and mechanistic studies in the field of RPE biology and AMD research.

Details

Title
A Novel Method of Mouse RPE Explant Culture and Effective Introduction of Transgenes Using Adenoviral Transduction for In Vitro Studies in AMD
Author
Shang, Peng 1 ; Stepicheva, Nadezda A 1 ; Liu, Haitao 1 ; Chowdhury, Olivia 1 ; Franks, Jonathan 2 ; Sun, Ming 2 ; Hose, Stacey 1 ; Ghosh, Sayan 1 ; Yazdankhah, Meysam 1 ; Strizhakova, Anastasia 1 ; Donna Beer Stolz 2 ; ZiglerJr, J Samuel 3 ; Sinha, Debasish 1 

 Department of Ophthalmology, Children’s Hospital of University of Pittsburgh School of Medicine, One Children’s Hospital Drive, 4401 Penn Avenue, Pittsburgh, PA 15224, USA; [email protected] (N.A.S.); [email protected] (H.L.); [email protected] (O.C.); [email protected] (S.H.); [email protected] (S.G.); [email protected] (M.Y.); [email protected] (A.S.); [email protected] (D.S.) 
 Department of Cell Biology and Center for Biologic Imaging, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA; [email protected] (J.F.); [email protected] (M.S.); [email protected] (D.B.S.) 
 Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA; [email protected] 
First page
11979
Publication year
2021
Publication date
2021
Publisher
MDPI AG
ISSN
16616596
e-ISSN
14220067
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2596040349
Copyright
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.